ஜர்னல் ஆஃப் அனஸ்தீசியாலஜி மற்றும் வலி ஆராய்ச்சி

Pain is defined as an unpleasant sensation in the body, owing to ongoing or impending tissue damage. Pain management is one of the most frequently dealt-with issues by clinicians for any disease. Pharmacological therapy is the first line of therapy, followed by treatment via devices in severe pain management cases.

Based on drug class, the market is segmented into NSAIDs, anesthetics, anticonvulsants, antimigraine agents, antidepressants, opioids, and nonnarcotic analgesics. Moreover, the segment is further divided into tramadol, hydrocodone, oxycodone, and others. Based on indication, the market is divided into arthritic pain, neuropathic pain, cancer pain, chronic back pain, postoperative pain, migraine, and fibromyalgia. The cancer pain segment is expected to manifest the highest CAGR during the study period, owing to increase in prevalence of cancer across the world. The postoperative pain and chronic back pain together held the largest share in 2017, owing to rise in number of surgeries globally and rise in prevalence of chronic diseases leading to back pain.